Serial 99257154
Live / Allowed — Published for opposition (as of 10 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 27 Jun 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99257154
- Mark type
- Design / logo
- Filed
- 27 Jun 2025
- Published for opposition
- 10 Mar 2026
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 001 — Chemicals: Plant growth promoters and plant growth regulators in the nature of plant hormones for promoting plant growth, and biological soil and plant soil amendments for use in agriculture and horticulture; seed microbial inoculants and soil inoculants for use in agriculture and horticulture; biochemicals, namely, biological signal molecules in the nature of agricultural and horticultural chemicals, except fungicides, herbicides, insecticides and parasiticides, namely, natural and synthetic plant hormones, biological fertilizers, granulated fertilizers, and chemical additives for use in the manufacture of pesticides, insecticides, herbicides, biological pesticides, biological insecticides, and granulated pesticides that improve plant health and enhance growth of agricultural and horticultural crops; chemicals used in agriculture, horticulture and forestry, except fungicides, herbicides, insecticides and parasiticides, namely seed treatment preparations; fertilizers for agricultural, domestic, horticultural, ornamental and commercial use; chemical preparations for the treatment of seeds and plants for agricultural use
- Class 003 — Cosmetics and cleaning preparations: Cosmetic skin and hair care preparations for use in connection with the improvement in the appearance of human skin
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for suppressing tumors and treatment of cancer; pharmaceuticals for use in the treatment of immunological and inflammation-related disease and disorders, fibrotic diseases and disorders, neurosensory-related diseases and disorders, and metabolic diseases and disorders; house mark for a full line of veterinary preparations for treatment of cancer, immunological and inflammation-related disease and disorders, fibrotic diseases and disorders, neurosensory-related diseases and disorders, and metabolic diseases and disorders for use in connection with companion and farm animals
- Class 031 — Natural agricultural products: Agricultural, horticultural and forestry products, namely, seeds and bulbs for agricultural and horticultural purposes, seedlings, live plant grafts, and plugs being seedlings or live rooted plant cuttings and planting soil sold as a unit; raw and unprocessed agricultural and horticultural products, namely, plant biomass being organic matter derived from live plants; natural live plants, rootstocks and flowers; live bulbs, seedlings, plant bulb divisions in the nature of live plant cuttings being parts of live plants, micropropagated seeds for agricultural and horticultural purposes, tissue-cultured seedlings, and seeds for planting for agricultural and horticultural purposes; agricultural and aqua-cultural crops, namely, crop seeds for agricultural and horticultural purposes and live plant cuttings and divisions being parts of live plants; horticulture and forestry products, namely, unprocessed seeds for planting for aqua-cultural and forestry use
- Class 042 — Scientific and technological services: Pharmaceutical research and development services; scientific research and development of pharmaceutical preparations; pharmaceutical research services, namely, developing new uses for pharmaceutical compounds through the use of computer models, animal models, and controlled environments; contract scientific research services in support of scientific research and development of pharmaceutical preparations; technical consultancy and services in relation to technical research in the field of pharmaceuticals, namely, pharmaceutical research and development; consultancy in relation to scientific research in the field of pharmaceuticals; providing medical research and scientific research information in the field of medicine and pharmaceuticals; drug discovery services; Scientific and technological services, namely, scientific research and design for others in the field of pharmaceuticals and conducting and evaluating clinical trials for others; software as a service (SaaS) services featuring software enabling users to diagnose medical conditions, prescribe medical treatment and prescriptions, design clinical trials and forecast clinical trial results, search for clinical trial patients, analyze data, and develop pharmaceutical products and chemical compounds
Owner
- Enveda Therapeutics, Inc., Boulder, CO, US
- Enveda Therapeutics, Inc., Boulder, CO, US
Prosecution history
- 10 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Mar 2026 — PUBLISHED FOR OPPOSITION
- 04 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Feb 2026 — EXAMINER'S AMENDMENT ENTERED
- 13 Feb 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 13 Feb 2026 — EXAMINERS AMENDMENT E-MAILED
- 13 Feb 2026 — EXAMINERS AMENDMENT -WRITTEN
- 13 Feb 2026 — PREVIOUS ALLOWANCE COUNT WITHDRAWN
- 10 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Feb 2026 — EXAMINER'S AMENDMENT ENTERED
- 10 Feb 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 10 Feb 2026 — EXAMINERS AMENDMENT E-MAILED
- 10 Feb 2026 — EXAMINERS AMENDMENT -WRITTEN
- 10 Feb 2026 — EXAMINER'S AMENDMENT ENTERED